F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition

F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition

The New York Times - Business:

The move by the commission is seen as a test of regulators’ efforts to prevent big companies from buying small innovators.

This post first appeared in The New York Times - Business. Read the original article.